Study identifier:D5180R00027
ClinicalTrials.gov identifier:NCT06455462
EudraCT identifier:N/A
CTIS identifier:N/A
Patient characteristics, treatment patterns and outcomes of patients enrolled in the Tezepelumab Patient Access Programme; a retrospective, observational medical chart review conducted in UK severe asthma centres
Severe Asthma
N/A
No
Tezepelumab
All
200
Observational
18 Years - 100 Years
Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Aug 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|